Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study of GKT in Diabetes Related Dementia
Sponsor: Shanghai 10th People's Hospital
Summary
Recently a new clinical dementia subgroup based on brain imaging, called "diabetes related dementia (DrD)". DrD, unlike Alzheimer's disease and vascular dementia, is considered a "controllable" or "modifiable" form of dementia. However, there is currently a lack of corresponding treatment measures. Ginkgo biloba ketone ester tablets are extracts of Ginkgo biloba leaves. Previous studies have shown that they can increase cerebral blood flow, reduce cerebrovascular resistance, improve cerebral circulation, and are beneficial for the treatment of cognitive impairment. This project intends to explore the role of ginkgo ketoester tablets in diabetes related dementia through a multicenter randomized double-blind controlled clinical study.
Official title: Clinical Study of Ginkgo Biloba Ketone Ester Tablets in Diabetes Related Dementia
Key Details
Gender
All
Age Range
60 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
370
Start Date
2023-12-01
Completion Date
2026-06-30
Last Updated
2023-11-13
Healthy Volunteers
No
Conditions
Interventions
Ginkgo Ketone Ester Tablets
Ginkgo Ketone Ester Tablets taken orally, 3 times a day, 0.5g each time, combined with conventional hypoglycemic treatment for six months
placebo
placebo, taken orally, 3 times a day, 0.5g each time, combined with conventional hypoglycemic treatment for six months